Skip to main content

FAMOTIDINE

NDC 67877-843 · Ascend Laboratories, LLC

Generic nameFAMOTIDINE

Dosage formTABLET, FILM COATED

RouteORAL

Active ingredient(s)FAMOTIDINE

Strength40 mg/1

Pharmacologic classHistamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]

Marketing categoryANDA

Packages

67877-843-01 — 100 TABLET, FILM COATED in 1 BOTTLE (67877-843-01)

67877-843-05 — 500 TABLET, FILM COATED in 1 BOTTLE (67877-843-05)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

67296-2186 — Famotidine, 67296-2264 — Famotidine, 67457-433 — Famotidine, 67457-448 — Famotidine, 67457-457 — Famotidine, 67751-202 — Famotidine, Calcium carbonate, and Magnesium hydroxide, 67751-214 — Famotidine, 67877-626 — Ibuprofen and famotidine, 67877-775 — Famotidine, 67877-842 — FAMOTIDINE, 67877-889 — FAMOTIDINE, 68001-397 — Famotidine, 68001-398 — Famotidine, 68001-494 — Famotidine, 68016-800 — Famotidine, 68016-801 — Famotidine, 68071-2306 — Famotidine, 68071-3201 — Famotidine, 68071-3413 — FAMOTIDINE, 68071-3420 — FAMOTIDINE, +401 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels